| 0 |
INTRAMYELINIC OEDEMA |
11 |
0.7333 |
| 1 |
ENLARGED FOETAL CISTERNA MAGNA |
3 |
0.6000 |
| 2 |
TALIPES CORRECTION |
4 |
0.5714 |
| 3 |
RETINAL FUNCTION TEST ABNORMAL |
5 |
0.4545 |
| 4 |
INFANTILE SPASMS |
311 |
0.4302 |
| 5 |
RETINOGRAM ABNORMAL |
114 |
0.4254 |
| 6 |
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY WITH BURST-SUPPRESSION |
5 |
0.4167 |
| 7 |
CORTICAL VISUAL IMPAIRMENT |
19 |
0.3276 |
| 8 |
MAGNETIC RESONANCE IMAGING HEAD ABNORMAL |
202 |
0.3112 |
| 9 |
DRUG WITHDRAWAL CONVULSIONS |
482 |
0.2708 |
| 10 |
KETOGENIC DIET |
4 |
0.2222 |
| 11 |
BENIGN CARDIAC NEOPLASM |
7 |
0.2121 |
| 12 |
INFANTILE SPITTING UP |
83 |
0.1587 |
| 13 |
LISSENCEPHALY |
7 |
0.1522 |
| 14 |
DIFFUSION-WEIGHTED BRAIN MRI ABNORMAL |
4 |
0.1481 |
| 15 |
EPILEPTIC ENCEPHALOPATHY |
30 |
0.1345 |
| 16 |
POLYNEUROPATHY IDIOPATHIC PROGRESSIVE |
8 |
0.1194 |
| 17 |
OPHTHALMOLOGICAL EXAMINATION ABNORMAL |
21 |
0.1186 |
| 18 |
LENNOX-GASTAUT SYNDROME |
26 |
0.1145 |
| 19 |
COMA BLISTER |
10 |
0.1111 |
| 20 |
TUBEROUS SCLEROSIS COMPLEX |
11 |
0.1048 |
| 21 |
INVOLUNTARY VOCALISATION |
3 |
0.1034 |
| 22 |
MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL |
17 |
0.0939 |
| 23 |
GLYCOGEN STORAGE DISORDER |
3 |
0.0857 |
| 24 |
ABDOMINAL WALL CYST |
10 |
0.0820 |
| 25 |
MILD MENTAL RETARDATION |
3 |
0.0769 |
| 26 |
INFANT IRRITABILITY |
7 |
0.0714 |
| 27 |
ELECTROENCEPHALOGRAM |
4 |
0.0714 |
| 28 |
BASILAR MIGRAINE |
4 |
0.0635 |
| 29 |
CHANGE IN SEIZURE PRESENTATION |
41 |
0.0634 |
| 30 |
ASTROCYTOMA, LOW GRADE |
10 |
0.0588 |
| 31 |
MULTIPLE-DRUG RESISTANCE |
180 |
0.0580 |
| 32 |
TRACHEOSTOMY INFECTION |
7 |
0.0574 |
| 33 |
MITOCHONDRIAL ENCEPHALOMYOPATHY |
4 |
0.0563 |
| 34 |
SEIZURE CLUSTER |
45 |
0.0543 |
| 35 |
INABILITY TO CRAWL |
3 |
0.0517 |
| 36 |
BRAIN LOBECTOMY |
3 |
0.0508 |
| 37 |
CORTICAL DYSPLASIA |
3 |
0.0508 |
| 38 |
CEREBRAL DYSGENESIS |
3 |
0.0500 |
| 39 |
POSTICTAL PARALYSIS |
12 |
0.0496 |
| 40 |
BACTERIAL TRACHEITIS |
4 |
0.0494 |
| 41 |
SUDDEN UNEXPLAINED DEATH IN EPILEPSY |
26 |
0.0486 |
| 42 |
TONIC CONVULSION |
64 |
0.0451 |
| 43 |
ATONIC SEIZURES |
36 |
0.0419 |
| 44 |
ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC |
27 |
0.0415 |
| 45 |
EPIDURAL LIPOMATOSIS |
14 |
0.0407 |
| 46 |
FOETAL VALPROATE SYNDROME |
4 |
0.0400 |
| 47 |
NEONATAL BEHAVIOURAL SYNDROME |
12 |
0.0392 |
| 48 |
BODY DYSMORPHIC DISORDER |
14 |
0.0373 |
| 49 |
DEVELOPMENTAL REGRESSION |
5 |
0.0368 |
| 50 |
GINGIVAL ATROPHY |
7 |
0.0357 |
| 51 |
HYPERINTENSITY IN BRAIN DEEP NUCLEI |
3 |
0.0357 |
| 52 |
BRAIN OPERATION |
79 |
0.0346 |
| 53 |
OPTIC ATROPHY |
53 |
0.0325 |
| 54 |
MYOCLONIC EPILEPSY |
49 |
0.0323 |
| 55 |
LEUKODYSTROPHY |
3 |
0.0323 |
| 56 |
TEMPORAL LOBE EPILEPSY |
13 |
0.0297 |
| 57 |
RETINAL DYSTROPHY |
7 |
0.0294 |
| 58 |
ENTEROVIRUS INFECTION |
25 |
0.0289 |
| 59 |
FUNDOSCOPY ABNORMAL |
3 |
0.0288 |
| 60 |
FEEDING INTOLERANCE |
13 |
0.0288 |
| 61 |
PLAGIOCEPHALY |
14 |
0.0281 |
| 62 |
VESICOURETERIC REFLUX |
11 |
0.0272 |
| 63 |
FACIAL DYSMORPHISM |
6 |
0.0271 |
| 64 |
NEUROSURGERY |
5 |
0.0270 |
| 65 |
THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION |
10 |
0.0270 |
| 66 |
FOCAL DYSCOGNITIVE SEIZURES |
30 |
0.0263 |
| 67 |
RETINAL TOXICITY |
27 |
0.0262 |
| 68 |
ABSENCE OF IMMEDIATE TREATMENT RESPONSE |
6 |
0.0253 |
| 69 |
INFANTILE VOMITING |
5 |
0.0253 |
| 70 |
ANAL ATRESIA |
13 |
0.0243 |
| 71 |
NEONATAL SEIZURE |
6 |
0.0241 |
| 72 |
ADENOTONSILLECTOMY |
6 |
0.0240 |
| 73 |
FEBRILE CONVULSION |
29 |
0.0238 |
| 74 |
STATUS EPILEPTICUS |
268 |
0.0237 |
| 75 |
MAGNETIC RESONANCE IMAGING ABNORMAL |
28 |
0.0234 |
| 76 |
CARNITINE DEFICIENCY |
4 |
0.0234 |
| 77 |
BONE METABOLISM DISORDER |
7 |
0.0233 |
| 78 |
SEIZURE |
2669 |
0.0231 |
| 79 |
INTELLECTUAL DISABILITY |
35 |
0.0230 |
| 80 |
RHINOVIRUS INFECTION |
87 |
0.0223 |
| 81 |
EXCESSIVE EYE BLINKING |
33 |
0.0223 |
| 82 |
GAZE PALSY |
38 |
0.0223 |
| 83 |
RETINAL DISORDER |
58 |
0.0223 |
| 84 |
SHUNT MALFUNCTION |
6 |
0.0212 |
| 85 |
TRACHEITIS |
16 |
0.0210 |
| 86 |
RELAPSING FEVER |
6 |
0.0208 |
| 87 |
TRACHEO-OESOPHAGEAL FISTULA |
13 |
0.0203 |
| 88 |
TRACHEOMALACIA |
8 |
0.0203 |
| 89 |
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL |
29 |
0.0199 |
| 90 |
THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION |
9 |
0.0199 |
| 91 |
VISUAL FIELD DEFECT |
142 |
0.0196 |
| 92 |
LOW SET EARS |
8 |
0.0195 |
| 93 |
RETINAL INJURY |
15 |
0.0194 |
| 94 |
CHOREOATHETOSIS |
13 |
0.0191 |
| 95 |
AUTOMATISM |
4 |
0.0185 |
| 96 |
DYSMETRIA |
11 |
0.0182 |
| 97 |
COMPLEX PARTIAL SEIZURES |
20 |
0.0180 |
| 98 |
PARTIAL SEIZURES |
94 |
0.0179 |
| 99 |
POOR SUCKING REFLEX |
7 |
0.0176 |
| 100 |
PYROGLUTAMIC ACIDOSIS |
7 |
0.0176 |
| 101 |
PARTIAL SEIZURES WITH SECONDARY GENERALISATION |
8 |
0.0171 |
| 102 |
BLINDNESS CORTICAL |
8 |
0.0163 |
| 103 |
BULIMIA NERVOSA |
7 |
0.0159 |
| 104 |
NEUROTRANSMITTER LEVEL ALTERED |
3 |
0.0159 |
| 105 |
HAND-FOOT-AND-MOUTH DISEASE |
13 |
0.0157 |
| 106 |
PYLORIC STENOSIS |
13 |
0.0153 |
| 107 |
RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS |
12 |
0.0153 |
| 108 |
BODY MASS INDEX DECREASED |
7 |
0.0151 |
| 109 |
GASTROSTOMY TUBE SITE COMPLICATION |
3 |
0.0150 |
| 110 |
PRODUCT CONTAMINATION |
53 |
0.0149 |
| 111 |
MICROPHTHALMOS |
4 |
0.0147 |
| 112 |
HEAD BANGING |
8 |
0.0140 |
| 113 |
CLONIC CONVULSION |
10 |
0.0137 |
| 114 |
ELECTROENCEPHALOGRAM ABNORMAL |
43 |
0.0136 |
| 115 |
RETINAL DEPIGMENTATION |
4 |
0.0131 |
| 116 |
ADENOIDECTOMY |
5 |
0.0129 |
| 117 |
MUSCLE TONE DISORDER |
4 |
0.0128 |
| 118 |
BRONCHIOLITIS |
45 |
0.0128 |
| 119 |
CROUP INFECTIOUS |
10 |
0.0127 |
| 120 |
HYPOTONIA |
119 |
0.0119 |
| 121 |
STRABISMUS |
35 |
0.0119 |
| 122 |
AMBLYOPIA |
7 |
0.0118 |
| 123 |
CLEFT LIP AND PALATE |
13 |
0.0116 |
| 124 |
GASTROSTOMY |
18 |
0.0116 |
| 125 |
RETINAL DEGENERATION |
15 |
0.0115 |
| 126 |
GASTROINTESTINAL VIRAL INFECTION |
12 |
0.0115 |
| 127 |
CERVICOBRACHIAL SYNDROME |
7 |
0.0114 |
| 128 |
OPEN ANGLE GLAUCOMA |
7 |
0.0114 |
| 129 |
ASTERIXIS |
12 |
0.0113 |
| 130 |
HEMIANOPIA HOMONYMOUS |
8 |
0.0109 |
| 131 |
BRAIN SCAN ABNORMAL |
6 |
0.0108 |
| 132 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
93 |
0.0107 |
| 133 |
CHOREA |
18 |
0.0104 |
| 134 |
AVERSION |
3 |
0.0104 |
| 135 |
STARING |
25 |
0.0103 |
| 136 |
OPISTHOTONUS |
8 |
0.0101 |
| 137 |
EPILEPSY |
306 |
0.0100 |
| 138 |
DEPENDENCE ON RESPIRATOR |
4 |
0.0100 |
| 139 |
DERMATITIS DIAPER |
7 |
0.0099 |
| 140 |
SIMPLE PARTIAL SEIZURES |
8 |
0.0099 |
| 141 |
ANTICONVULSANT DRUG LEVEL DECREASED |
14 |
0.0099 |
| 142 |
RESPIRATORY TRACT INFECTION VIRAL |
22 |
0.0094 |
| 143 |
CONGENITAL NOSE MALFORMATION |
5 |
0.0094 |
| 144 |
HYPERCHLORAEMIA |
6 |
0.0094 |
| 145 |
MULTIPLE DRUG THERAPY |
7 |
0.0093 |
| 146 |
EYE MOVEMENT DISORDER |
63 |
0.0092 |
| 147 |
SELF-DESTRUCTIVE BEHAVIOUR |
8 |
0.0092 |
| 148 |
HAEMANGIOMA |
21 |
0.0091 |
| 149 |
OCULAR TOXICITY |
10 |
0.0091 |
| 150 |
LARYNGOMALACIA |
3 |
0.0090 |
| 151 |
PRECOCIOUS PUBERTY |
5 |
0.0088 |
| 152 |
WHITE MATTER LESION |
11 |
0.0087 |
| 153 |
HYPOSPADIAS |
18 |
0.0086 |
| 154 |
INCREASED BRONCHIAL SECRETION |
22 |
0.0086 |
| 155 |
PARAINFLUENZAE VIRUS INFECTION |
13 |
0.0085 |
| 156 |
BRAIN MALFORMATION |
3 |
0.0084 |
| 157 |
FOREIGN BODY ASPIRATION |
6 |
0.0083 |
| 158 |
POSTURE ABNORMAL |
27 |
0.0083 |
| 159 |
PETIT MAL EPILEPSY |
42 |
0.0082 |
| 160 |
OPTIC NERVE DISORDER |
13 |
0.0081 |
| 161 |
ADENOIDAL HYPERTROPHY |
3 |
0.0079 |
| 162 |
BREATH HOLDING |
3 |
0.0078 |
| 163 |
CEREBRAL VENTRICLE DILATATION |
9 |
0.0078 |
| 164 |
INTENTIONAL UNDERDOSE |
56 |
0.0077 |
| 165 |
METAPNEUMOVIRUS INFECTION |
6 |
0.0077 |
| 166 |
DROPPED HEAD SYNDROME |
3 |
0.0076 |
| 167 |
PNEUMONIA MYCOPLASMAL |
6 |
0.0075 |
| 168 |
HYDROCELE |
8 |
0.0075 |
| 169 |
ANTICONVULSANT DRUG LEVEL INCREASED |
12 |
0.0074 |
| 170 |
ANHIDROSIS |
3 |
0.0074 |
| 171 |
GENERALISED TONIC-CLONIC SEIZURE |
119 |
0.0072 |
| 172 |
APNOEIC ATTACK |
4 |
0.0071 |
| 173 |
CORONA VIRUS INFECTION |
3 |
0.0070 |
| 174 |
ROTAVIRUS INFECTION |
4 |
0.0069 |
| 175 |
MENTAL DISABILITY |
4 |
0.0069 |
| 176 |
ASPIRATION |
74 |
0.0067 |
| 177 |
AMINO ACID LEVEL INCREASED |
5 |
0.0067 |
| 178 |
UPPER RESPIRATORY TRACT INFLAMMATION |
8 |
0.0067 |
| 179 |
MENINGOMYELOCELE |
4 |
0.0067 |
| 180 |
ASTIGMATISM |
10 |
0.0066 |
| 181 |
DRUG RESISTANCE |
168 |
0.0065 |
| 182 |
NEURODEGENERATIVE DISORDER |
4 |
0.0065 |
| 183 |
EATING DISORDER SYMPTOM |
3 |
0.0065 |
| 184 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
8 |
0.0064 |
| 185 |
STEREOTYPY |
6 |
0.0064 |
| 186 |
RETINAL PIGMENTATION |
5 |
0.0063 |
| 187 |
CEREBRAL PALSY |
6 |
0.0063 |
| 188 |
HYPERMETROPIA |
6 |
0.0063 |
| 189 |
INAPPROPRIATE AFFECT |
10 |
0.0063 |
| 190 |
PNEUMONIA NECROTISING |
4 |
0.0062 |
| 191 |
HYPOVENTILATION |
20 |
0.0061 |
| 192 |
HYPERKINESIA |
13 |
0.0061 |
| 193 |
DRUG DOSE OMISSION |
990 |
0.0060 |
| 194 |
SCREAMING |
38 |
0.0060 |
| 195 |
NEURODEVELOPMENTAL DISORDER |
4 |
0.0059 |
| 196 |
AMMONIA INCREASED |
30 |
0.0059 |
| 197 |
TONGUE MOVEMENT DISTURBANCE |
5 |
0.0058 |
| 198 |
HEAD TITUBATION |
8 |
0.0058 |
| 199 |
POSTICTAL STATE |
6 |
0.0058 |
| 200 |
OTITIS MEDIA |
19 |
0.0057 |
| 201 |
MITRAL VALVE DISEASE |
10 |
0.0056 |
| 202 |
PNEUMONIA VIRAL |
18 |
0.0056 |
| 203 |
BITE |
4 |
0.0055 |
| 204 |
MANUFACTURING PRODUCT SHIPPING ISSUE |
3 |
0.0055 |
| 205 |
DROOLING |
38 |
0.0055 |
| 206 |
PNEUMONIA ASPIRATION |
137 |
0.0055 |
| 207 |
CEREBRAL DISORDER |
40 |
0.0054 |
| 208 |
TONSILLECTOMY |
9 |
0.0054 |
| 209 |
LIFE SUPPORT |
3 |
0.0053 |
| 210 |
ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC |
4 |
0.0053 |
| 211 |
POOR QUALITY PRODUCT ADMINISTERED |
55 |
0.0052 |
| 212 |
GASTROINTESTINAL TUBE INSERTION |
13 |
0.0052 |
| 213 |
RESPIRATORY DISTRESS |
143 |
0.0052 |
| 214 |
RESPIRATORY DISORDER |
150 |
0.0050 |
| 215 |
REFLUX GASTRITIS |
6 |
0.0050 |
| 216 |
BRONCHOPULMONARY DYSPLASIA |
4 |
0.0050 |
| 217 |
CHRONIC RESPIRATORY FAILURE |
6 |
0.0050 |
| 218 |
PSYCHOMOTOR SKILLS IMPAIRED |
13 |
0.0050 |
| 219 |
HYDROCEPHALUS |
27 |
0.0050 |
| 220 |
INCORRECT DRUG DOSAGE FORM ADMINISTERED |
3 |
0.0049 |
| 221 |
PRESCRIBED OVERDOSE |
95 |
0.0049 |
| 222 |
TRACHEOSTOMY |
7 |
0.0049 |
| 223 |
IRRITABILITY |
293 |
0.0049 |
| 224 |
GRAND MAL CONVULSION |
44 |
0.0048 |
| 225 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
4 |
0.0047 |
| 226 |
RECALLED PRODUCT ADMINISTERED |
45 |
0.0047 |
| 227 |
NYSTAGMUS |
25 |
0.0047 |
| 228 |
CONVULSION |
267 |
0.0047 |
| 229 |
EMERGENCY CARE |
14 |
0.0046 |
| 230 |
FOOD REFUSAL |
4 |
0.0046 |
| 231 |
DEVELOPMENTAL DELAY |
41 |
0.0045 |
| 232 |
MACROCYTOSIS |
5 |
0.0043 |
| 233 |
PSYCHOGENIC SEIZURE |
4 |
0.0043 |
| 234 |
CEREBRAL ATROPHY |
17 |
0.0043 |
| 235 |
BEHAVIOUR DISORDER |
23 |
0.0042 |
| 236 |
DYSMORPHISM |
10 |
0.0042 |
| 237 |
NEPHROCALCINOSIS |
5 |
0.0042 |
| 238 |
FOETAL ANTICONVULSANT SYNDROME |
5 |
0.0042 |
| 239 |
EAR INFECTION |
112 |
0.0042 |
| 240 |
CONGENITAL HYDRONEPHROSIS |
3 |
0.0042 |
| 241 |
PERSONALITY DISORDER |
11 |
0.0042 |
| 242 |
SPEECH DISORDER DEVELOPMENTAL |
12 |
0.0042 |
| 243 |
CARDIAC SEPTAL DEFECT |
3 |
0.0042 |
| 244 |
NASAL INJURY |
3 |
0.0042 |
| 245 |
NOROVIRUS INFECTION |
6 |
0.0042 |
| 246 |
LARYNGEAL DISORDER |
3 |
0.0042 |
| 247 |
ALANINE AMINOTRANSFERASE DECREASED |
3 |
0.0041 |
| 248 |
TOXIC ENCEPHALOPATHY |
20 |
0.0039 |
| 249 |
INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION |
3 |
0.0039 |
| 250 |
PLEURAL FIBROSIS |
4 |
0.0039 |
| 251 |
PSYCHOMOTOR RETARDATION |
11 |
0.0039 |
| 252 |
HYPOTONIA NEONATAL |
6 |
0.0038 |
| 253 |
FEEDING DISORDER NEONATAL |
4 |
0.0038 |
| 254 |
ABNORMAL BEHAVIOUR |
149 |
0.0038 |
| 255 |
TUNNEL VISION |
7 |
0.0037 |
| 256 |
LEARNING DISORDER |
9 |
0.0037 |
| 257 |
SALIVARY HYPERSECRETION |
36 |
0.0036 |
| 258 |
FACIAL SPASM |
4 |
0.0036 |
| 259 |
ENCEPHALOPATHY |
87 |
0.0035 |
| 260 |
PRODUCT PREPARATION ERROR |
72 |
0.0035 |
| 261 |
CRYING |
127 |
0.0035 |
| 262 |
REGURGITATION |
12 |
0.0035 |
| 263 |
INCORRECT DOSAGE ADMINISTERED |
17 |
0.0035 |
| 264 |
ADENOVIRUS INFECTION |
10 |
0.0034 |
| 265 |
SPINA BIFIDA |
7 |
0.0034 |
| 266 |
GINGIVAL HYPERTROPHY |
5 |
0.0033 |
| 267 |
DRUG DOSE TITRATION NOT PERFORMED |
6 |
0.0033 |
| 268 |
OTITIS EXTERNA |
4 |
0.0033 |
| 269 |
GASTRIC OPERATION |
3 |
0.0033 |
| 270 |
AGGRESSION |
163 |
0.0033 |
| 271 |
VIRAL INFECTION |
108 |
0.0032 |
| 272 |
ACUTE RESPIRATORY FAILURE |
62 |
0.0032 |
| 273 |
ATAXIA |
38 |
0.0032 |
| 274 |
NEUROTOXICITY |
55 |
0.0031 |
| 275 |
APNOEA |
24 |
0.0031 |
| 276 |
TONIC CLONIC MOVEMENTS |
4 |
0.0031 |
| 277 |
STRIDOR |
9 |
0.0031 |
| 278 |
LISTLESS |
10 |
0.0030 |
| 279 |
PSYCHOMOTOR HYPERACTIVITY |
50 |
0.0030 |
| 280 |
SOMNOLENCE |
603 |
0.0030 |
| 281 |
SEIZURE LIKE PHENOMENA |
5 |
0.0029 |
| 282 |
FAILURE TO THRIVE |
15 |
0.0029 |
| 283 |
HYPOPNOEA |
10 |
0.0029 |
| 284 |
HEART DISEASE CONGENITAL |
10 |
0.0028 |
| 285 |
PRODUCT SUPPLY ISSUE |
20 |
0.0028 |
| 286 |
INTRACRANIAL VENOUS SINUS THROMBOSIS |
3 |
0.0028 |
| 287 |
ADVERSE EVENT |
257 |
0.0028 |
| 288 |
SEDATION |
73 |
0.0028 |
| 289 |
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY |
3 |
0.0028 |
| 290 |
GASTROENTERITIS VIRAL |
50 |
0.0028 |
| 291 |
PRODUCT PREPARATION ISSUE |
18 |
0.0027 |
| 292 |
NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL |
9 |
0.0027 |
| 293 |
HYPERTHERMIA MALIGNANT |
4 |
0.0027 |
| 294 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
7 |
0.0027 |
| 295 |
HYDRONEPHROSIS |
20 |
0.0027 |
| 296 |
HYPERCAPNIA |
8 |
0.0027 |
| 297 |
HYPERTONIA |
15 |
0.0026 |
| 298 |
FOLATE DEFICIENCY |
3 |
0.0026 |
| 299 |
BRADYPNOEA |
7 |
0.0026 |
| 300 |
CLUMSINESS |
7 |
0.0026 |
| 301 |
CLONUS |
7 |
0.0026 |
| 302 |
HYPORESPONSIVE TO STIMULI |
3 |
0.0026 |
| 303 |
LETHARGY |
147 |
0.0026 |
| 304 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
12 |
0.0025 |
| 305 |
MYOCLONUS |
30 |
0.0025 |
| 306 |
RESPIRATORY TRACT INFECTION |
65 |
0.0025 |
| 307 |
DIABETES INSIPIDUS |
6 |
0.0025 |
| 308 |
HOSPITALISATION |
374 |
0.0024 |
| 309 |
PARAPLEGIA |
7 |
0.0024 |
| 310 |
QUADRIPARESIS |
4 |
0.0024 |
| 311 |
BRAIN NEOPLASM |
22 |
0.0024 |
| 312 |
DYSKINESIA |
97 |
0.0024 |
| 313 |
HYPERSOMNIA |
68 |
0.0024 |
| 314 |
OPTIC NEUROPATHY |
5 |
0.0024 |
| 315 |
FEELING OF DESPAIR |
11 |
0.0024 |
| 316 |
COMMUNICATION DISORDER |
9 |
0.0024 |
| 317 |
PHYSICAL DECONDITIONING |
6 |
0.0023 |
| 318 |
DRUG TITRATION ERROR |
6 |
0.0023 |
| 319 |
LANGUAGE DISORDER |
5 |
0.0023 |
| 320 |
HYPOPITUITARISM |
4 |
0.0023 |
| 321 |
HIRSUTISM |
3 |
0.0023 |
| 322 |
RESPIRATORY FAILURE |
164 |
0.0022 |
| 323 |
CALCULUS BLADDER |
3 |
0.0022 |
| 324 |
AUTISM SPECTRUM DISORDER |
12 |
0.0022 |
| 325 |
DRUG LEVEL DECREASED |
22 |
0.0022 |
| 326 |
AURA |
4 |
0.0021 |
| 327 |
INCREASED UPPER AIRWAY SECRETION |
11 |
0.0021 |
| 328 |
RESPIRATORY RATE INCREASED |
19 |
0.0021 |
| 329 |
LIP DISORDER |
4 |
0.0021 |
| 330 |
MULTIPLE CONGENITAL ABNORMALITIES |
3 |
0.0021 |
| 331 |
GINGIVAL DISORDER |
8 |
0.0021 |
| 332 |
CLEFT PALATE |
4 |
0.0021 |
| 333 |
PNEUMONIA BACTERIAL |
19 |
0.0021 |
| 334 |
HYPOTHALAMO-PITUITARY DISORDER |
3 |
0.0021 |
| 335 |
PRODUCT ADMINISTRATION INTERRUPTED |
16 |
0.0020 |
| 336 |
GENE MUTATION |
4 |
0.0020 |
| 337 |
HYPERAMMONAEMIA |
10 |
0.0020 |
| 338 |
MUSCLE TWITCHING |
46 |
0.0020 |
| 339 |
SLEEP TERROR |
8 |
0.0019 |
| 340 |
RESPIRATION ABNORMAL |
13 |
0.0019 |
| 341 |
RENAL NEOPLASM |
4 |
0.0019 |
| 342 |
HYPOVOLAEMIC SHOCK |
9 |
0.0019 |
| 343 |
CUSHINGOID |
6 |
0.0019 |
| 344 |
SYMPTOM RECURRENCE |
11 |
0.0018 |
| 345 |
DRUG LEVEL INCREASED |
30 |
0.0018 |
| 346 |
HYPERNATRAEMIA |
9 |
0.0018 |
| 347 |
LINEAR IGA DISEASE |
3 |
0.0018 |
| 348 |
THERAPY PARTIAL RESPONDER |
28 |
0.0018 |
| 349 |
CYANOSIS |
28 |
0.0018 |
| 350 |
HYPOTHERMIA |
18 |
0.0018 |
| 351 |
OXYGEN SATURATION ABNORMAL |
5 |
0.0018 |
| 352 |
THERAPY NON-RESPONDER |
79 |
0.0018 |
| 353 |
DISEASE COMPLICATION |
8 |
0.0017 |
| 354 |
BLEPHAROSPASM |
11 |
0.0017 |
| 355 |
EYE OPERATION |
8 |
0.0017 |
| 356 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
3 |
0.0017 |
| 357 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
5 |
0.0017 |
| 358 |
WRONG PATIENT RECEIVED PRODUCT |
5 |
0.0017 |
| 359 |
PNEUMONIA |
549 |
0.0017 |
| 360 |
MACULOPATHY |
6 |
0.0017 |
| 361 |
BRUXISM |
9 |
0.0017 |
| 362 |
WEIGHT ABNORMAL |
4 |
0.0017 |
| 363 |
MOOD ALTERED |
45 |
0.0016 |
| 364 |
UPPER RESPIRATORY TRACT INFECTION |
76 |
0.0016 |
| 365 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
10 |
0.0016 |
| 366 |
RENAL CYST |
13 |
0.0016 |
| 367 |
RESPIRATORY ARREST |
45 |
0.0016 |
| 368 |
METAMORPHOPSIA |
3 |
0.0016 |
| 369 |
THERAPY CHANGE |
16 |
0.0016 |
| 370 |
TALIPES |
5 |
0.0016 |
| 371 |
JOINT DISLOCATION |
17 |
0.0016 |
| 372 |
ACUTE PULMONARY OEDEMA |
9 |
0.0016 |
| 373 |
URINE OUTPUT DECREASED |
14 |
0.0016 |
| 374 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
58 |
0.0016 |
| 375 |
BLINDNESS |
65 |
0.0016 |
| 376 |
PRODUCT DOSE OMISSION |
104 |
0.0016 |
| 377 |
FACE INJURY |
6 |
0.0016 |
| 378 |
HYPOREFLEXIA |
3 |
0.0016 |
| 379 |
AGITATION |
114 |
0.0016 |
| 380 |
APATHY |
22 |
0.0015 |
| 381 |
BRAIN INJURY |
15 |
0.0015 |
| 382 |
DYSTONIA |
29 |
0.0015 |
| 383 |
POTENTIATING DRUG INTERACTION |
5 |
0.0015 |
| 384 |
FOAMING AT MOUTH |
3 |
0.0015 |
| 385 |
JAW DISORDER |
8 |
0.0015 |
| 386 |
BRONCHOPNEUMONIA |
5 |
0.0015 |
| 387 |
DRUG LEVEL BELOW THERAPEUTIC |
8 |
0.0014 |
| 388 |
SURGERY |
85 |
0.0014 |
| 389 |
MICROCYTIC ANAEMIA |
3 |
0.0014 |
| 390 |
ENDOTRACHEAL INTUBATION |
4 |
0.0014 |
| 391 |
VISUAL IMPAIRMENT |
176 |
0.0014 |
| 392 |
ANAEMIA MACROCYTIC |
3 |
0.0014 |
| 393 |
PRODUCT DISPENSING ISSUE |
6 |
0.0014 |
| 394 |
POOR QUALITY SLEEP |
30 |
0.0014 |
| 395 |
FACIAL PALSY |
3 |
0.0014 |
| 396 |
OXYGEN SATURATION DECREASED |
78 |
0.0014 |
| 397 |
CHOKING |
27 |
0.0014 |
| 398 |
FEEDING DISORDER |
28 |
0.0014 |
| 399 |
TOOTH DISCOLOURATION |
4 |
0.0014 |
| 400 |
RETINOPATHY |
5 |
0.0013 |
| 401 |
ANGER |
45 |
0.0013 |
| 402 |
HYPOPHAGIA |
34 |
0.0013 |
| 403 |
PNEUMOTHORAX |
21 |
0.0013 |
| 404 |
UNRESPONSIVE TO STIMULI |
34 |
0.0013 |
| 405 |
BUNDLE BRANCH BLOCK RIGHT |
6 |
0.0013 |
| 406 |
MASTICATION DISORDER |
4 |
0.0013 |
| 407 |
MATERNAL DRUGS AFFECTING FOETUS |
10 |
0.0013 |
| 408 |
EYELID DISORDER |
3 |
0.0013 |
| 409 |
NEUROLOGICAL DECOMPENSATION |
3 |
0.0013 |
| 410 |
HIP SURGERY |
7 |
0.0013 |
| 411 |
APHTHOUS ULCER |
10 |
0.0013 |
| 412 |
ADVERSE REACTION |
17 |
0.0013 |
| 413 |
PRODUCT DOSE OMISSION ISSUE |
376 |
0.0013 |
| 414 |
SECRETION DISCHARGE |
16 |
0.0013 |
| 415 |
MOVEMENT DISORDER |
41 |
0.0013 |
| 416 |
RESPIRATORY RATE DECREASED |
4 |
0.0013 |
| 417 |
MYOPIA |
3 |
0.0013 |
| 418 |
MALNUTRITION |
14 |
0.0013 |
| 419 |
STUPOR |
4 |
0.0012 |
| 420 |
OEDEMA MOUTH |
4 |
0.0012 |
| 421 |
NEOPLASM |
14 |
0.0012 |
| 422 |
HYPERURICAEMIA |
5 |
0.0012 |
| 423 |
FEELING DRUNK |
9 |
0.0012 |
| 424 |
METABOLIC DISORDER |
7 |
0.0012 |
| 425 |
URINE ODOUR ABNORMAL |
7 |
0.0012 |
| 426 |
MOTOR DYSFUNCTION |
12 |
0.0012 |
| 427 |
ESCHERICHIA URINARY TRACT INFECTION |
5 |
0.0012 |
| 428 |
VISUAL ACUITY REDUCED |
39 |
0.0012 |
| 429 |
HORDEOLUM |
5 |
0.0012 |
| 430 |
HYPERREFLEXIA |
4 |
0.0011 |
| 431 |
TREATMENT FAILURE |
95 |
0.0011 |
| 432 |
AFFECTIVE DISORDER |
9 |
0.0011 |
| 433 |
MUSCLE CONTRACTIONS INVOLUNTARY |
4 |
0.0011 |
| 434 |
GINGIVAL SWELLING |
5 |
0.0011 |
| 435 |
MOOD SWINGS |
36 |
0.0011 |
| 436 |
NORMAL NEWBORN |
6 |
0.0011 |
| 437 |
FAECES SOFT |
8 |
0.0011 |
| 438 |
NONSPECIFIC REACTION |
6 |
0.0011 |
| 439 |
DRUG INEFFECTIVE |
1436 |
0.0011 |
| 440 |
HYPOPHOSPHATAEMIA |
8 |
0.0011 |
| 441 |
STREPTOCOCCAL INFECTION |
6 |
0.0011 |
| 442 |
CONJUNCTIVITIS |
20 |
0.0011 |
| 443 |
BRADYCARDIA |
57 |
0.0011 |
| 444 |
LUNG CONSOLIDATION |
3 |
0.0011 |
| 445 |
COMA |
51 |
0.0011 |
| 446 |
METABOLIC ACIDOSIS |
34 |
0.0011 |
| 447 |
APPETITE DISORDER |
7 |
0.0011 |
| 448 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
18 |
0.0010 |
| 449 |
NEUROLOGICAL SYMPTOM |
6 |
0.0010 |
| 450 |
PSEUDOMONAS INFECTION |
9 |
0.0010 |
| 451 |
INFLUENZA |
117 |
0.0010 |
| 452 |
PROCEDURAL COMPLICATION |
8 |
0.0010 |
| 453 |
APHAGIA |
5 |
0.0010 |
| 454 |
FINE MOTOR SKILL DYSFUNCTION |
3 |
0.0010 |
| 455 |
DEATH |
891 |
0.0010 |
| 456 |
PRODUCT TASTE ABNORMAL |
14 |
0.0010 |
| 457 |
CONGENITAL ANOMALY |
8 |
0.0010 |
| 458 |
EATING DISORDER |
22 |
0.0010 |
| 459 |
VOMITING |
480 |
0.0010 |
| 460 |
ALTERED STATE OF CONSCIOUSNESS |
22 |
0.0010 |
| 461 |
THERAPY CESSATION |
52 |
0.0010 |
| 462 |
EYE DISORDER |
33 |
0.0010 |
| 463 |
HYPERPHAGIA |
4 |
0.0010 |
| 464 |
DERMATITIS EXFOLIATIVE |
5 |
0.0010 |
| 465 |
SPINAL FUSION SURGERY |
4 |
0.0010 |
| 466 |
PRODUCT USE ISSUE |
185 |
0.0010 |
| 467 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
54 |
0.0010 |
| 468 |
DYSCHEZIA |
3 |
0.0010 |
| 469 |
ORAL PAIN |
22 |
0.0010 |
| 470 |
SLEEP DISORDER |
69 |
0.0010 |
| 471 |
GOITRE |
4 |
0.0010 |
| 472 |
CONDITION AGGRAVATED |
297 |
0.0010 |
| 473 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
6 |
0.0010 |
| 474 |
ADVERSE DRUG REACTION |
87 |
0.0010 |
| 475 |
DIPLOPIA |
25 |
0.0010 |
| 476 |
MYOCARDITIS |
11 |
0.0010 |
| 477 |
MALABSORPTION |
5 |
0.0010 |
| 478 |
RESTLESSNESS |
35 |
0.0010 |
| 479 |
TACHYPNOEA |
13 |
0.0010 |
| 480 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
68 |
0.0010 |
| 481 |
BLOOD LACTIC ACID INCREASED |
5 |
0.0009 |
| 482 |
HEAD INJURY |
30 |
0.0009 |
| 483 |
DRUG INTERACTION |
150 |
0.0009 |
| 484 |
AORTIC VALVE INCOMPETENCE |
4 |
0.0009 |
| 485 |
INSOMNIA |
248 |
0.0009 |
| 486 |
HAEMODYNAMIC INSTABILITY |
7 |
0.0009 |
| 487 |
TIC |
5 |
0.0009 |
| 488 |
MIDDLE INSOMNIA |
17 |
0.0009 |
| 489 |
RETCHING |
19 |
0.0009 |
| 490 |
PAPILLOEDEMA |
4 |
0.0009 |
| 491 |
EYE INFECTION |
10 |
0.0009 |
| 492 |
PSYCHOTIC DISORDER |
26 |
0.0009 |
| 493 |
ACCIDENTAL OVERDOSE |
32 |
0.0009 |
| 494 |
EAR DISORDER |
4 |
0.0009 |
| 495 |
ENCEPHALITIS |
6 |
0.0009 |
| 496 |
LOGORRHOEA |
3 |
0.0009 |
| 497 |
NEPHROLITHIASIS |
39 |
0.0008 |
| 498 |
ENERGY INCREASED |
5 |
0.0008 |
| 499 |
SLEEP APNOEA SYNDROME |
16 |
0.0008 |
| 500 |
URINARY TRACT INFECTION |
143 |
0.0008 |
| 501 |
INCREASED APPETITE |
16 |
0.0008 |
| 502 |
PULMONARY CONGESTION |
11 |
0.0008 |
| 503 |
FOOD INTOLERANCE |
3 |
0.0008 |
| 504 |
RESPIRATORY TRACT CONGESTION |
13 |
0.0008 |
| 505 |
TREMOR |
135 |
0.0008 |
| 506 |
BREATH SOUNDS ABNORMAL |
4 |
0.0008 |
| 507 |
PYREXIA |
280 |
0.0008 |
| 508 |
PYELONEPHRITIS |
7 |
0.0008 |
| 509 |
SCOLIOSIS |
5 |
0.0008 |
| 510 |
NERVOUS SYSTEM DISORDER |
25 |
0.0008 |
| 511 |
PRODUCT AVAILABILITY ISSUE |
18 |
0.0008 |
| 512 |
COORDINATION ABNORMAL |
11 |
0.0008 |
| 513 |
NASOPHARYNGITIS |
145 |
0.0008 |
| 514 |
BOWEL MOVEMENT IRREGULARITY |
6 |
0.0008 |
| 515 |
INITIAL INSOMNIA |
8 |
0.0008 |
| 516 |
HAEMOLYSIS |
6 |
0.0008 |
| 517 |
TONSILLITIS |
4 |
0.0008 |
| 518 |
WITHDRAWAL SYNDROME |
32 |
0.0008 |
| 519 |
CATATONIA |
4 |
0.0008 |
| 520 |
THERAPY INTERRUPTED |
54 |
0.0008 |
| 521 |
PRODUCT DISTRIBUTION ISSUE |
7 |
0.0008 |
| 522 |
MUSCLE RIGIDITY |
9 |
0.0008 |
| 523 |
THINKING ABNORMAL |
14 |
0.0008 |
| 524 |
JOINT INJURY |
16 |
0.0007 |
| 525 |
DYSPHAGIA |
71 |
0.0007 |
| 526 |
FUNGAL SKIN INFECTION |
3 |
0.0007 |
| 527 |
BRONCHITIS |
55 |
0.0007 |
| 528 |
ENURESIS |
3 |
0.0007 |
| 529 |
DECREASED ACTIVITY |
8 |
0.0007 |
| 530 |
PHARYNGITIS STREPTOCOCCAL |
8 |
0.0007 |
| 531 |
DRUG EXPOSURE DURING PREGNANCY |
25 |
0.0007 |
| 532 |
RESPIRATORY DEPRESSION |
9 |
0.0007 |
| 533 |
MUSCLE SPASTICITY |
9 |
0.0007 |
| 534 |
TOXICITY TO VARIOUS AGENTS |
123 |
0.0007 |
| 535 |
ACCIDENTAL EXPOSURE |
3 |
0.0007 |
| 536 |
MENTAL STATUS CHANGES |
20 |
0.0007 |
| 537 |
INSURANCE ISSUE |
11 |
0.0007 |
| 538 |
BRAIN OEDEMA |
9 |
0.0007 |
| 539 |
HEART RATE DECREASED |
25 |
0.0007 |
| 540 |
COGNITIVE DISORDER |
33 |
0.0007 |
| 541 |
PALLOR |
19 |
0.0007 |
| 542 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
5 |
0.0007 |
| 543 |
DISEASE RECURRENCE |
33 |
0.0007 |
| 544 |
URINARY RETENTION |
23 |
0.0007 |
| 545 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
27 |
0.0007 |
| 546 |
ORAL DISORDER |
5 |
0.0007 |
| 547 |
HYPOXIA |
24 |
0.0007 |
| 548 |
CARDIAC ARREST |
56 |
0.0007 |
| 549 |
PRODUCT SUBSTITUTION ISSUE |
39 |
0.0007 |
| 550 |
DRUG PRESCRIBING ERROR |
13 |
0.0007 |
| 551 |
DRUG EFFECT LESS THAN EXPECTED |
10 |
0.0007 |
| 552 |
HERNIA |
13 |
0.0007 |
| 553 |
ILEUS PARALYTIC |
3 |
0.0007 |
| 554 |
NASAL CONGESTION |
39 |
0.0007 |
| 555 |
DECREASED APPETITE |
153 |
0.0007 |
| 556 |
ACIDOSIS |
5 |
0.0007 |
| 557 |
SPEECH DISORDER |
34 |
0.0006 |
| 558 |
SKIN LACERATION |
7 |
0.0006 |
| 559 |
BACTERIAL INFECTION |
12 |
0.0006 |
| 560 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
130 |
0.0006 |
| 561 |
LACERATION |
6 |
0.0006 |
| 562 |
MULTIPLE ALLERGIES |
5 |
0.0006 |
| 563 |
INCORRECT DOSE ADMINISTERED |
145 |
0.0006 |
| 564 |
MYDRIASIS |
8 |
0.0006 |
| 565 |
MIOSIS |
5 |
0.0006 |
| 566 |
RHINITIS |
5 |
0.0006 |
| 567 |
MOUTH ULCERATION |
13 |
0.0006 |
| 568 |
GASTROENTERITIS |
9 |
0.0006 |
| 569 |
BLOOD POTASSIUM INCREASED |
10 |
0.0006 |
| 570 |
THIRST |
11 |
0.0006 |
| 571 |
HORMONE LEVEL ABNORMAL |
3 |
0.0006 |
| 572 |
DEHYDRATION |
82 |
0.0006 |
| 573 |
ASPHYXIA |
5 |
0.0006 |
| 574 |
BODY TEMPERATURE DECREASED |
6 |
0.0006 |
| 575 |
DRUG WITHDRAWAL SYNDROME NEONATAL |
9 |
0.0006 |
| 576 |
ESCHERICHIA INFECTION |
5 |
0.0006 |
| 577 |
ELECTROLYTE IMBALANCE |
7 |
0.0006 |
| 578 |
ILLNESS |
62 |
0.0006 |
| 579 |
CARDIO-RESPIRATORY ARREST |
25 |
0.0006 |
| 580 |
SEPTIC SHOCK |
26 |
0.0006 |
| 581 |
WRONG PRODUCT ADMINISTERED |
4 |
0.0006 |
| 582 |
HAEMATEMESIS |
15 |
0.0006 |
| 583 |
BLOOD SODIUM DECREASED |
11 |
0.0006 |
| 584 |
MUSCLE SPASMS |
107 |
0.0006 |
| 585 |
CARDIAC OPERATION |
5 |
0.0006 |
| 586 |
STOMATITIS |
35 |
0.0006 |
| 587 |
FORMICATION |
4 |
0.0006 |
| 588 |
INFECTION |
83 |
0.0006 |
| 589 |
POST PROCEDURAL COMPLICATION |
11 |
0.0006 |
| 590 |
WEIGHT INCREASED |
128 |
0.0006 |
| 591 |
DRUG INTOLERANCE |
55 |
0.0006 |
| 592 |
SMALL INTESTINAL OBSTRUCTION |
7 |
0.0006 |
| 593 |
EXTRAPYRAMIDAL DISORDER |
14 |
0.0006 |
| 594 |
THERMAL BURN |
4 |
0.0006 |
| 595 |
MUSCLE TIGHTNESS |
9 |
0.0006 |
| 596 |
CONSTIPATION |
121 |
0.0006 |
| 597 |
EMOTIONAL DISORDER |
17 |
0.0006 |
| 598 |
HYPOKINESIA |
8 |
0.0006 |
| 599 |
HYPONATRAEMIA |
31 |
0.0005 |
| 600 |
PANCREATITIS |
29 |
0.0005 |
| 601 |
FAECALOMA |
3 |
0.0005 |
| 602 |
DENTAL CARIES |
6 |
0.0005 |
| 603 |
IRON DEFICIENCY ANAEMIA |
5 |
0.0005 |
| 604 |
PERSONALITY CHANGE |
5 |
0.0005 |
| 605 |
HEART RATE ABNORMAL |
3 |
0.0005 |
| 606 |
MUSCULOSKELETAL STIFFNESS |
47 |
0.0005 |
| 607 |
PHOTOPHOBIA |
10 |
0.0005 |
| 608 |
HEMIPARESIS |
9 |
0.0005 |
| 609 |
OFF LABEL USE |
465 |
0.0005 |
| 610 |
MITRAL VALVE INCOMPETENCE |
6 |
0.0005 |
| 611 |
APHASIA |
16 |
0.0005 |
| 612 |
MENTAL DISORDER |
23 |
0.0005 |
| 613 |
RHINORRHOEA |
34 |
0.0005 |
| 614 |
SEPSIS |
58 |
0.0005 |
| 615 |
HYPERVENTILATION |
3 |
0.0005 |
| 616 |
ATELECTASIS |
5 |
0.0005 |
| 617 |
GASTROINTESTINAL DISORDER |
46 |
0.0005 |
| 618 |
PARKINSONISM |
5 |
0.0005 |
| 619 |
PULMONARY HAEMORRHAGE |
4 |
0.0005 |
| 620 |
COLD SWEAT |
9 |
0.0005 |
| 621 |
BLOOD TRIGLYCERIDES INCREASED |
9 |
0.0005 |
| 622 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
9 |
0.0005 |
| 623 |
FRUSTRATION TOLERANCE DECREASED |
4 |
0.0005 |
| 624 |
SEASONAL ALLERGY |
7 |
0.0005 |
| 625 |
PHARYNGITIS |
6 |
0.0005 |
| 626 |
MENSTRUAL DISORDER |
4 |
0.0005 |
| 627 |
ILEUS |
6 |
0.0005 |
| 628 |
UNDERDOSE |
35 |
0.0005 |
| 629 |
PETECHIAE |
5 |
0.0005 |
| 630 |
GASTRIC ULCER |
9 |
0.0005 |
| 631 |
INCONTINENCE |
5 |
0.0005 |
| 632 |
GASTROOESOPHAGEAL REFLUX DISEASE |
38 |
0.0005 |
| 633 |
PARANOIA |
8 |
0.0005 |
| 634 |
HYPERPROLACTINAEMIA |
3 |
0.0005 |
| 635 |
BRADYPHRENIA |
3 |
0.0005 |
| 636 |
CLOSTRIDIUM DIFFICILE INFECTION |
10 |
0.0005 |
| 637 |
DYSGRAPHIA |
3 |
0.0005 |
| 638 |
CORONAVIRUS INFECTION |
3 |
0.0005 |
| 639 |
SOPOR |
6 |
0.0005 |
| 640 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
10 |
0.0005 |
| 641 |
TOOTH DISORDER |
10 |
0.0004 |
| 642 |
MENINGITIS |
3 |
0.0004 |
| 643 |
QUALITY OF LIFE DECREASED |
6 |
0.0004 |
| 644 |
FEAR |
12 |
0.0004 |
| 645 |
SKIN INFECTION |
5 |
0.0004 |
| 646 |
INTENTIONAL SELF-INJURY |
9 |
0.0004 |
| 647 |
PRODUCT ADMINISTRATION ERROR |
9 |
0.0004 |
| 648 |
DISTURBANCE IN ATTENTION |
24 |
0.0004 |
| 649 |
PRODUCT USE COMPLAINT |
7 |
0.0004 |
| 650 |
REBOUND EFFECT |
5 |
0.0004 |
| 651 |
DRUG TOXICITY |
6 |
0.0004 |
| 652 |
SCIATICA |
7 |
0.0004 |
| 653 |
COUGH |
123 |
0.0004 |
| 654 |
PERIPHERAL COLDNESS |
6 |
0.0004 |
| 655 |
UROSEPSIS |
4 |
0.0004 |
| 656 |
THERAPEUTIC RESPONSE DECREASED |
26 |
0.0004 |
| 657 |
DISSEMINATED INTRAVASCULAR COAGULATION |
6 |
0.0004 |
| 658 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
19 |
0.0004 |
| 659 |
HEART RATE INCREASED |
42 |
0.0004 |
| 660 |
DRUG ADMINISTRATION ERROR |
13 |
0.0004 |
| 661 |
HYPOCALCAEMIA |
8 |
0.0004 |
| 662 |
DEAFNESS |
11 |
0.0004 |
| 663 |
GLAUCOMA |
8 |
0.0004 |
| 664 |
SINUS BRADYCARDIA |
4 |
0.0004 |
| 665 |
CIRCULATORY COLLAPSE |
7 |
0.0004 |
| 666 |
DYSSTASIA |
12 |
0.0004 |
| 667 |
MOUTH HAEMORRHAGE |
3 |
0.0004 |
| 668 |
HYPERCALCAEMIA |
5 |
0.0004 |
| 669 |
CYST |
5 |
0.0004 |
| 670 |
IMMUNODEFICIENCY |
6 |
0.0004 |
| 671 |
ABORTION SPONTANEOUS |
16 |
0.0004 |
| 672 |
POISONING |
5 |
0.0004 |
| 673 |
MALAISE |
173 |
0.0004 |
| 674 |
THROMBOCYTOPENIA |
44 |
0.0004 |
| 675 |
HYPERTHERMIA |
3 |
0.0004 |
| 676 |
SLUGGISHNESS |
4 |
0.0004 |
| 677 |
SHOCK |
9 |
0.0004 |
| 678 |
FALL |
130 |
0.0004 |
| 679 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
10 |
0.0004 |
| 680 |
LUNG INFECTION |
6 |
0.0004 |
| 681 |
HAEMORRHAGIC STROKE |
3 |
0.0004 |
| 682 |
SWELLING FACE |
25 |
0.0004 |
| 683 |
UNEVALUABLE EVENT |
29 |
0.0004 |
| 684 |
WEIGHT FLUCTUATION |
4 |
0.0004 |
| 685 |
PRODUCT ODOUR ABNORMAL |
4 |
0.0004 |
| 686 |
INCORRECT PRODUCT STORAGE |
5 |
0.0004 |
| 687 |
PRODUCT USE IN UNAPPROVED INDICATION |
94 |
0.0004 |
| 688 |
SUDDEN DEATH |
4 |
0.0004 |
| 689 |
BLOOD DISORDER |
3 |
0.0004 |
| 690 |
BLISTER |
21 |
0.0004 |
| 691 |
URINARY INCONTINENCE |
11 |
0.0004 |
| 692 |
BALANCE DISORDER |
32 |
0.0004 |
| 693 |
FRACTURE |
7 |
0.0004 |
| 694 |
LUNG DISORDER |
18 |
0.0004 |
| 695 |
CENTRAL NERVOUS SYSTEM LESION |
5 |
0.0004 |
| 696 |
FOOT DEFORMITY |
4 |
0.0004 |
| 697 |
HEMIPLEGIA |
3 |
0.0004 |
| 698 |
COAGULOPATHY |
6 |
0.0004 |
| 699 |
OBSTRUCTIVE AIRWAYS DISORDER |
4 |
0.0004 |
| 700 |
LYMPHOPENIA |
5 |
0.0004 |
| 701 |
GAIT DISTURBANCE |
67 |
0.0003 |
| 702 |
ANURIA |
3 |
0.0003 |
| 703 |
CARDIAC MURMUR |
3 |
0.0003 |
| 704 |
HYPOKALAEMIA |
16 |
0.0003 |
| 705 |
COMPLICATION ASSOCIATED WITH DEVICE |
5 |
0.0003 |
| 706 |
CAESAREAN SECTION |
4 |
0.0003 |
| 707 |
BODY TEMPERATURE INCREASED |
7 |
0.0003 |
| 708 |
AMENORRHOEA |
6 |
0.0003 |
| 709 |
MEDICATION ERROR |
19 |
0.0003 |
| 710 |
COVID-19 PNEUMONIA |
4 |
0.0003 |
| 711 |
GASTROINTESTINAL INFECTION |
3 |
0.0003 |
| 712 |
ANAL INCONTINENCE |
3 |
0.0003 |
| 713 |
LEUKOCYTOSIS |
6 |
0.0003 |
| 714 |
GENERAL PHYSICAL HEALTH DETERIORATION |
38 |
0.0003 |
| 715 |
GENERALISED OEDEMA |
4 |
0.0003 |
| 716 |
HEPATIC ENCEPHALOPATHY |
3 |
0.0003 |
| 717 |
DIARRHOEA HAEMORRHAGIC |
3 |
0.0003 |
| 718 |
COVID-19 |
56 |
0.0003 |
| 719 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
9 |
0.0003 |
| 720 |
INTENTIONAL DOSE OMISSION |
9 |
0.0003 |
| 721 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
5 |
0.0003 |
| 722 |
HYPERKALAEMIA |
11 |
0.0003 |
| 723 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
9 |
0.0003 |
| 724 |
RASH |
136 |
0.0003 |
| 725 |
NEUTROPENIA |
42 |
0.0003 |
| 726 |
MUSCULAR WEAKNESS |
35 |
0.0003 |
| 727 |
PLATELET COUNT INCREASED |
4 |
0.0003 |
| 728 |
NERVOUSNESS |
16 |
0.0003 |
| 729 |
KIDNEY INFECTION |
6 |
0.0003 |
| 730 |
DECREASED IMMUNE RESPONSIVENESS |
3 |
0.0003 |
| 731 |
EXPOSURE DURING PREGNANCY |
19 |
0.0003 |
| 732 |
HEPATOMEGALY |
3 |
0.0003 |
| 733 |
SKIN DISCOLOURATION |
14 |
0.0003 |
| 734 |
BEDRIDDEN |
4 |
0.0003 |
| 735 |
GASTRITIS |
8 |
0.0003 |
| 736 |
IMMUNE SYSTEM DISORDER |
4 |
0.0003 |
| 737 |
LIGAMENT SPRAIN |
3 |
0.0003 |
| 738 |
PHOTOSENSITIVITY REACTION |
5 |
0.0003 |
| 739 |
FATIGUE |
234 |
0.0003 |
| 740 |
BLOOD CHOLESTEROL INCREASED |
14 |
0.0003 |
| 741 |
PRODUCT PHYSICAL ISSUE |
6 |
0.0003 |
| 742 |
EPISTAXIS |
22 |
0.0003 |
| 743 |
PRODUCTIVE COUGH |
14 |
0.0003 |
| 744 |
GINGIVAL BLEEDING |
4 |
0.0003 |
| 745 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
3 |
0.0003 |
| 746 |
MATERNAL EXPOSURE DURING PREGNANCY |
26 |
0.0003 |
| 747 |
VISION BLURRED |
40 |
0.0003 |
| 748 |
FEMUR FRACTURE |
9 |
0.0003 |
| 749 |
HAEMATOCHEZIA |
16 |
0.0003 |
| 750 |
LOSS OF CONSCIOUSNESS |
37 |
0.0003 |
| 751 |
EYE DISCHARGE |
3 |
0.0003 |
| 752 |
HUNGER |
4 |
0.0003 |
| 753 |
MASS |
4 |
0.0003 |
| 754 |
SKIN REACTION |
4 |
0.0003 |
| 755 |
HEPATOCELLULAR INJURY |
4 |
0.0003 |
| 756 |
DIALYSIS |
4 |
0.0003 |
| 757 |
HYPERSENSITIVITY |
52 |
0.0003 |
| 758 |
PARALYSIS |
4 |
0.0003 |
| 759 |
SUBDURAL HAEMATOMA |
4 |
0.0003 |
| 760 |
VERTIGO |
17 |
0.0003 |
| 761 |
DISORIENTATION |
11 |
0.0003 |
| 762 |
OCULAR HYPERAEMIA |
13 |
0.0003 |
| 763 |
STAPHYLOCOCCAL INFECTION |
9 |
0.0003 |
| 764 |
LIVER DISORDER |
12 |
0.0003 |
| 765 |
STEVENS-JOHNSON SYNDROME |
6 |
0.0003 |
| 766 |
GAIT INABILITY |
9 |
0.0003 |
| 767 |
RASH PAPULAR |
6 |
0.0003 |
| 768 |
ECZEMA |
14 |
0.0003 |
| 769 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
19 |
0.0003 |
| 770 |
PREMATURE BABY |
8 |
0.0003 |
| 771 |
DYSPNOEA |
150 |
0.0003 |
| 772 |
DEPRESSED MOOD |
14 |
0.0003 |
| 773 |
MUSCULOSKELETAL DISORDER |
5 |
0.0003 |
| 774 |
DRUG DISPENSING ERROR |
4 |
0.0003 |
| 775 |
GASTRIC HAEMORRHAGE |
3 |
0.0003 |
| 776 |
DEVICE RELATED INFECTION |
4 |
0.0003 |
| 777 |
CELLULITIS |
13 |
0.0003 |
| 778 |
TREATMENT NONCOMPLIANCE |
14 |
0.0003 |
| 779 |
WEIGHT DECREASED |
71 |
0.0003 |
| 780 |
HALLUCINATION |
19 |
0.0003 |
| 781 |
CYSTITIS |
8 |
0.0003 |
| 782 |
INTENTIONAL PRODUCT USE ISSUE |
22 |
0.0003 |
| 783 |
HYPERLIPIDAEMIA |
3 |
0.0003 |
| 784 |
OVERDOSE |
54 |
0.0003 |
| 785 |
PREGNANCY |
5 |
0.0002 |
| 786 |
ADRENAL INSUFFICIENCY |
3 |
0.0002 |
| 787 |
EXTRA DOSE ADMINISTERED |
10 |
0.0002 |
| 788 |
FOETAL EXPOSURE DURING PREGNANCY |
20 |
0.0002 |
| 789 |
PULMONARY OEDEMA |
11 |
0.0002 |
| 790 |
DYSURIA |
9 |
0.0002 |
| 791 |
ABDOMINAL DISCOMFORT |
41 |
0.0002 |
| 792 |
MEMORY IMPAIRMENT |
33 |
0.0002 |
| 793 |
PULMONARY HYPERTENSION |
5 |
0.0002 |
| 794 |
CANDIDA INFECTION |
4 |
0.0002 |
| 795 |
HALLUCINATION, VISUAL |
5 |
0.0002 |
| 796 |
DISEASE PROGRESSION |
28 |
0.0002 |
| 797 |
DIZZINESS |
117 |
0.0002 |
| 798 |
ARRHYTHMIA |
11 |
0.0002 |
| 799 |
RASH GENERALISED |
6 |
0.0002 |
| 800 |
MULTI-ORGAN FAILURE |
4 |
0.0002 |
| 801 |
FAECES DISCOLOURED |
5 |
0.0002 |
| 802 |
FLUSHING |
23 |
0.0002 |
| 803 |
DRUG DEPENDENCE |
36 |
0.0002 |
| 804 |
THERAPEUTIC RESPONSE UNEXPECTED |
10 |
0.0002 |
| 805 |
OEDEMA PERIPHERAL |
27 |
0.0002 |
| 806 |
TOOTHACHE |
4 |
0.0002 |
| 807 |
LIMB INJURY |
6 |
0.0002 |
| 808 |
AKATHISIA |
3 |
0.0002 |
| 809 |
PERICARDIAL EFFUSION |
5 |
0.0002 |
| 810 |
AMNESIA |
14 |
0.0002 |
| 811 |
RENAL DISORDER |
10 |
0.0002 |
| 812 |
SUICIDE ATTEMPT |
13 |
0.0002 |
| 813 |
DISCOMFORT |
13 |
0.0002 |
| 814 |
TARDIVE DYSKINESIA |
6 |
0.0002 |
| 815 |
PRODUCT DOSE OMISSION IN ERROR |
6 |
0.0002 |
| 816 |
FLATULENCE |
12 |
0.0002 |
| 817 |
COLITIS |
8 |
0.0002 |
| 818 |
BLOOD URINE PRESENT |
4 |
0.0002 |
| 819 |
PRODUCT PRESCRIBING ERROR |
5 |
0.0002 |
| 820 |
CARDIOGENIC SHOCK |
3 |
0.0002 |
| 821 |
LOWER LIMB FRACTURE |
4 |
0.0002 |
| 822 |
DIARRHOEA |
134 |
0.0002 |
| 823 |
MENTAL IMPAIRMENT |
5 |
0.0002 |
| 824 |
EAR PAIN |
4 |
0.0002 |
| 825 |
SINUSITIS |
21 |
0.0002 |
| 826 |
TACHYCARDIA |
18 |
0.0002 |
| 827 |
ABASIA |
5 |
0.0002 |
| 828 |
UPPER LIMB FRACTURE |
4 |
0.0002 |
| 829 |
BLOOD POTASSIUM DECREASED |
6 |
0.0002 |
| 830 |
CARDIAC FAILURE |
16 |
0.0002 |
| 831 |
NO ADVERSE EVENT |
36 |
0.0002 |
| 832 |
LACRIMATION INCREASED |
6 |
0.0002 |
| 833 |
LOWER RESPIRATORY TRACT INFECTION |
9 |
0.0002 |
| 834 |
ACNE |
15 |
0.0002 |
| 835 |
DELUSION |
3 |
0.0002 |
| 836 |
DRUG-INDUCED LIVER INJURY |
6 |
0.0002 |
| 837 |
MUCOSAL INFLAMMATION |
5 |
0.0002 |
| 838 |
CONFUSIONAL STATE |
30 |
0.0002 |
| 839 |
HYPOGLYCAEMIA |
9 |
0.0002 |
| 840 |
WHEEZING |
11 |
0.0002 |
| 841 |
HAEMOGLOBIN DECREASED |
19 |
0.0002 |
| 842 |
PNEUMONITIS |
5 |
0.0002 |
| 843 |
PRODUCT PRESCRIBING ISSUE |
4 |
0.0002 |
| 844 |
MANIA |
3 |
0.0002 |
| 845 |
HYPERTENSION |
38 |
0.0002 |
| 846 |
HAEMOPTYSIS |
5 |
0.0002 |
| 847 |
ANAEMIA |
34 |
0.0002 |
| 848 |
PANCREATITIS ACUTE |
4 |
0.0002 |
| 849 |
ASTHMA |
20 |
0.0002 |
| 850 |
FEELING ABNORMAL |
42 |
0.0002 |
| 851 |
RASH MACULAR |
6 |
0.0002 |
| 852 |
OSTEOPOROSIS |
7 |
0.0002 |
| 853 |
LABORATORY TEST ABNORMAL |
5 |
0.0002 |
| 854 |
CATARACT |
10 |
0.0002 |
| 855 |
RHABDOMYOLYSIS |
7 |
0.0002 |
| 856 |
DRUG EFFECT DECREASED |
9 |
0.0002 |
| 857 |
HEPATIC FAILURE |
5 |
0.0002 |
| 858 |
C-REACTIVE PROTEIN INCREASED |
6 |
0.0002 |
| 859 |
ILL-DEFINED DISORDER |
10 |
0.0002 |
| 860 |
ANAPHYLACTIC REACTION |
9 |
0.0002 |
| 861 |
ABDOMINAL DISTENSION |
17 |
0.0002 |
| 862 |
HYPOACUSIS |
7 |
0.0002 |
| 863 |
ASTHENIA |
61 |
0.0002 |
| 864 |
EYE SWELLING |
6 |
0.0002 |
| 865 |
LEUKOPENIA |
8 |
0.0002 |
| 866 |
DRUG WITHDRAWAL SYNDROME |
14 |
0.0002 |
| 867 |
EYE PAIN |
9 |
0.0002 |
| 868 |
FOOT FRACTURE |
3 |
0.0002 |
| 869 |
FEELING JITTERY |
3 |
0.0002 |
| 870 |
MIGRAINE |
15 |
0.0002 |
| 871 |
WHITE BLOOD CELL COUNT INCREASED |
6 |
0.0002 |
| 872 |
CHOLESTASIS |
3 |
0.0002 |
| 873 |
DEPRESSION |
35 |
0.0002 |
| 874 |
JOINT STIFFNESS |
4 |
0.0002 |
| 875 |
EXPIRED PRODUCT ADMINISTERED |
5 |
0.0002 |
| 876 |
LIP SWELLING |
5 |
0.0001 |
| 877 |
MENSTRUATION IRREGULAR |
4 |
0.0001 |
| 878 |
JAUNDICE |
4 |
0.0001 |
| 879 |
TYPE 2 DIABETES MELLITUS |
5 |
0.0001 |
| 880 |
PLEURAL EFFUSION |
9 |
0.0001 |
| 881 |
ANXIETY |
42 |
0.0001 |
| 882 |
NEUTROPHIL COUNT DECREASED |
6 |
0.0001 |
| 883 |
BLOOD GLUCOSE DECREASED |
7 |
0.0001 |
| 884 |
POLLAKIURIA |
6 |
0.0001 |
| 885 |
ROAD TRAFFIC ACCIDENT |
6 |
0.0001 |
| 886 |
PANCYTOPENIA |
8 |
0.0001 |
| 887 |
ALOPECIA |
28 |
0.0001 |
| 888 |
SUICIDAL IDEATION |
13 |
0.0001 |
| 889 |
PRODUCT QUALITY ISSUE |
19 |
0.0001 |
| 890 |
HERPES ZOSTER |
8 |
0.0001 |
| 891 |
SWELLING |
13 |
0.0001 |
| 892 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
25 |
0.0001 |
| 893 |
URTICARIA |
23 |
0.0001 |
| 894 |
PANIC ATTACK |
5 |
0.0001 |
| 895 |
INTENTIONAL PRODUCT MISUSE |
12 |
0.0001 |
| 896 |
RENAL FAILURE |
18 |
0.0001 |
| 897 |
HYPOTENSION |
27 |
0.0001 |
| 898 |
HAEMORRHAGE |
14 |
0.0001 |
| 899 |
HEPATIC ENZYME INCREASED |
9 |
0.0001 |
| 900 |
ERYTHEMA |
27 |
0.0001 |
| 901 |
ABDOMINAL PAIN UPPER |
27 |
0.0001 |
| 902 |
FEELING HOT |
8 |
0.0001 |
| 903 |
INJURY |
9 |
0.0001 |
| 904 |
RASH ERYTHEMATOUS |
6 |
0.0001 |
| 905 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
6 |
0.0001 |
| 906 |
HIP FRACTURE |
4 |
0.0001 |
| 907 |
HYPERHIDROSIS |
16 |
0.0001 |
| 908 |
BLOOD CREATININE INCREASED |
8 |
0.0001 |
| 909 |
DYSGEUSIA |
9 |
0.0001 |
| 910 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 911 |
EYE PRURITUS |
4 |
0.0001 |
| 912 |
RENAL FAILURE ACUTE |
5 |
0.0001 |
| 913 |
HEPATITIS |
3 |
0.0001 |
| 914 |
GASTRIC DISORDER |
4 |
0.0001 |
| 915 |
NEOPLASM PROGRESSION |
4 |
0.0001 |
| 916 |
CONTUSION |
11 |
0.0001 |
| 917 |
ALANINE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 918 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
4 |
0.0001 |
| 919 |
MOBILITY DECREASED |
8 |
0.0001 |
| 920 |
ELECTROCARDIOGRAM QT PROLONGED |
4 |
0.0001 |
| 921 |
MYELOSUPPRESSION |
4 |
0.0001 |
| 922 |
BLOOD BILIRUBIN INCREASED |
3 |
0.0001 |
| 923 |
CHILLS |
13 |
0.0001 |
| 924 |
SYNCOPE |
11 |
0.0001 |
| 925 |
INFLUENZA LIKE ILLNESS |
9 |
0.0001 |
| 926 |
DYSARTHRIA |
4 |
0.0001 |
| 927 |
NAUSEA |
84 |
0.0001 |
| 928 |
PERIPHERAL SWELLING |
16 |
0.0001 |
| 929 |
HEADACHE |
65 |
0.0001 |
| 930 |
INTERSTITIAL LUNG DISEASE |
5 |
0.0001 |
| 931 |
LIVER FUNCTION TEST ABNORMAL |
3 |
0.0001 |
| 932 |
DYSPHONIA |
6 |
0.0001 |
| 933 |
FLUID RETENTION |
5 |
0.0001 |
| 934 |
OROPHARYNGEAL PAIN |
9 |
0.0001 |
| 935 |
INFLAMMATION |
5 |
0.0001 |
| 936 |
CARDIAC DISORDER |
9 |
0.0001 |
| 937 |
ASPARTATE AMINOTRANSFERASE INCREASED |
5 |
0.0001 |
| 938 |
OEDEMA |
5 |
0.0001 |
| 939 |
CHOLELITHIASIS |
3 |
0.0001 |
| 940 |
DYSPEPSIA |
9 |
0.0001 |
| 941 |
DEPENDENCE |
5 |
0.0001 |
| 942 |
BLOOD PRESSURE DECREASED |
6 |
0.0001 |
| 943 |
FUNGAL INFECTION |
3 |
0.0001 |
| 944 |
ARTHROPATHY |
5 |
0.0001 |
| 945 |
DELIRIUM |
3 |
0.0001 |
| 946 |
ABDOMINAL PAIN |
20 |
0.0001 |
| 947 |
LYMPHADENOPATHY |
3 |
0.0001 |
| 948 |
PLATELET COUNT DECREASED |
9 |
0.0001 |
| 949 |
CEREBRAL HAEMORRHAGE |
3 |
0.0001 |
| 950 |
PAIN |
51 |
0.0001 |
| 951 |
DRUG EFFECT INCOMPLETE |
3 |
0.0001 |
| 952 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 953 |
INTESTINAL OBSTRUCTION |
3 |
0.0001 |
| 954 |
MUSCULOSKELETAL PAIN |
4 |
0.0001 |
| 955 |
EYE IRRITATION |
4 |
0.0001 |
| 956 |
ANGIOEDEMA |
3 |
0.0001 |
| 957 |
HOT FLUSH |
5 |
0.0001 |
| 958 |
BLOOD PRESSURE INCREASED |
10 |
0.0001 |
| 959 |
INTENTIONAL OVERDOSE |
4 |
0.0001 |
| 960 |
DRY EYE |
3 |
0.0001 |
| 961 |
GASTROINTESTINAL HAEMORRHAGE |
5 |
0.0001 |
| 962 |
EMOTIONAL DISTRESS |
7 |
0.0001 |
| 963 |
ARTHRALGIA |
24 |
0.0001 |
| 964 |
PARAESTHESIA |
9 |
0.0001 |
| 965 |
DERMATITIS ATOPIC |
3 |
0.0001 |
| 966 |
WHITE BLOOD CELL COUNT DECREASED |
6 |
0.0001 |
| 967 |
PAIN IN EXTREMITY |
16 |
0.0001 |
| 968 |
CHEST PAIN |
10 |
0.0001 |
| 969 |
NECK PAIN |
3 |
0.0001 |
| 970 |
CEREBROVASCULAR ACCIDENT |
9 |
0.0001 |
| 971 |
CHRONIC KIDNEY DISEASE |
4 |
0.0001 |
| 972 |
DIABETES MELLITUS |
4 |
0.0001 |
| 973 |
DRY SKIN |
7 |
0.0001 |
| 974 |
INJECTION SITE HAEMORRHAGE |
4 |
0.0001 |
| 975 |
THROMBOSIS |
4 |
0.0000 |
| 976 |
JOINT SWELLING |
6 |
0.0000 |
| 977 |
DRY MOUTH |
4 |
0.0000 |
| 978 |
ACCIDENTAL EXPOSURE TO PRODUCT |
5 |
0.0000 |
| 979 |
SKIN EXFOLIATION |
4 |
0.0000 |
| 980 |
PRURITUS |
18 |
0.0000 |
| 981 |
ACUTE KIDNEY INJURY |
7 |
0.0000 |
| 982 |
NEOPLASM MALIGNANT |
3 |
0.0000 |
| 983 |
DEVICE MALFUNCTION |
3 |
0.0000 |
| 984 |
ARTHRITIS |
3 |
0.0000 |
| 985 |
PALPITATIONS |
4 |
0.0000 |
| 986 |
HYPOAESTHESIA |
5 |
0.0000 |
| 987 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 988 |
BACK PAIN |
6 |
0.0000 |
| 989 |
MYALGIA |
4 |
0.0000 |
| 990 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 991 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 992 |
INJECTION SITE PAIN |
3 |
0.0000 |